Skip to content

Effects of Resistance Training on Cardiovascular Risk Factors in Middle Aged Women

Effects of Different Models of Undulating Periodization of Resistance Training on Cardiovascular Risk Parameters, Body Composition, Muscle Strength and Lifespam in Premenopausal Women with Metabolic Syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6gdyvz
Enrollment
Unknown
Registered
2012-12-12
Start date
2012-04-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women with different genotypes of polymorphism of the Angiotensin Converting Enzyme (ACE)

Interventions

Clinical randomized controlled trial, double-blind, 3 arms. Women between 18 and 49 years will be voluntarily recruited from the local community. Each volunteer you be submitted to general physical ex
2) Resistance training - will be performed with weekly and daily undulating periodization models. En the daily undulating model, training intensity will be increased in each day of the week, for examp
3) Anthropometry
4)Body composition - body composition analysis of the volunteers, before and after the training period will be done by the Dual-energy X-ray absorptiometry
5)Blood pressure - the measure of systolic (SBP) and diastolic blood pressure (DBP), in weeks 0, 12 and 24 will be done by the auscultatory method
6) Cytokines measure - plasma cytokines and resistin, and salivary immunoglobulin A - saliva drawn will be performed to remove cells from the oral mucosa. Then, swabs tips will be separated with sciss
other
E02.779.483.875

Sponsors

Universidade Católica de Brasília
Lead Sponsor
Universidade Católica de Brasília
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 49 Years

Inclusion criteria

Inclusion criteria: To be pre-menopausal aged between 18-49 years and no regular practice of exercise in the previous 12 months

Exclusion criteria

Exclusion criteria: Use of drugs that could affect cardiovascular response to exercise and presence of any disease that would compromise their health during the study period.

Design outcomes

Primary

MeasureTime frame
Improvement of the metabolic profile measured by blood cytokines, lipidogram, insulin and glucose

Secondary

MeasureTime frame
Decrease of the cardiovascular risk factors, also measured by blood pressure parameters after six months

Countries

Brazil

Contacts

Public ContactRamires Tibana

Universidade Católica de Brasília

ramiires@hotmail.com+55(61)9616-8340

Outcome results

None listed

Source: REBEC (via WHO ICTRP)